Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation

Recruiting N/A Interventional Study
Healthy Newborn Infants
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
2 Hours and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
125 (estimated)
Sponsor
Turku University Hospital · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim is to study whether the microbiota of children who are exposed to antibiotics at birth could be modified by synbiotic supplement and thereby reduce the risk of obesity, chronic diseases and respiratory tract infections. A total of 125 mother-child pairs will be recruited in this randomized, double-blind, placebo-controlled study. Infants are randomized to receive either a synbiotic supplem…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Pregnant women (n=125) and their newborn children who receive antibiotic treatment at delivery. Exclusion Criteria: * Chorioamnionitis * Pre-eclampsia and hepatogestosis * Suspected malformation or serious condition of the foetus and neonates * Serious infection or other condi…
Contacts

Paula Tähtinen, MD, PhD

+358-2-3130746

paula.tahtinen@utu.fi

CONTACT